ResearcherCalifornia University of Science and MedicineActive in the last 2 years

Tiantian Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3290-180X; OpenAlex author ID A5023921014. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D. Co-author DOI 10.1016/j.celrep.2025.116596 ↗
Chmp1A regulates pancreatic cancer cell growth via SIM-medicated SUMOylation and UIM-mediated ubiquitination, opposed through NLS-mediated signaling activities Co-author DOI 10.21203/rs.3.rs-3702688/v1 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Devin Sakamoto · 1 shared paper, 2023 · strength 0.22
- Paper Chmp1A regulates pancreatic cancer cell growth via SIM-medicated SUMOylation and UIM-mediated ubiquitination, opposed t… DOI 10.21203/rs.3.rs-3702688/v1 ↗
Maiyon Park · 1 shared paper, 2023 · strength 0.22
- Paper Chmp1A regulates pancreatic cancer cell growth via SIM-medicated SUMOylation and UIM-mediated ubiquitination, opposed t… DOI 10.21203/rs.3.rs-3702688/v1 ↗
Kui Ming Chan · 1 shared paper, 2025 · strength 0.21
- Paper Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohisto… DOI 10.1016/j.celrep.2025.116596 ↗
Landon Long Chan · 1 shared paper, 2025 · strength 0.21
- Paper Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohisto… DOI 10.1016/j.celrep.2025.116596 ↗
Xin Wang · 1 shared paper, 2025 · strength 0.21
- Paper Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohisto… DOI 10.1016/j.celrep.2025.116596 ↗
Yi Ching Esther Wan · 1 shared paper, 2025 · strength 0.21
- Paper Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohisto… DOI 10.1016/j.celrep.2025.116596 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.